학술논문
Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial
Document Type
Article
Author
Source
In International Journal of Infectious Diseases January 2022 114:165-174
Subject
Language
ISSN
1201-9712